Webinar: Challenges and Opportunities for Co-Morbid Substance Use Disorder and Major Depressive Disorder
Location: Online Via PsychU.org
Description: Approximately one third of patients with Major Depressive Disorder (MDD) also have a substance use disorder (SUD). Depending on the type of substance, a wide range of effects on MDD symptomatology can occur, particularly depending on where in the cycle of recovery from the SUD. In this webinar, Dr. Robin Nelson, MD and Dr. Roueen Rafeyan, MD will discuss the challenges and opportunities for treating co-morbid SUD in MDD, including the impact of different substances on the symptomatology of MDD.
Speakers are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Not a member? Sign up for free!
Join us as we continue our efforts towards improving the future of mental health care through
information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!